Centrose LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centrose LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10607
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centrose LLC (Centrose) is a precision drug company that develops medicines to target diseased tissues. The company’s product pipeline includes EDC1 (Dysadherin), EDC2 (CD147), EDC3 (CD98), EDC5 (CD44), and EDC8 (CD38). Its product EDC1 combines two proteins found in close proximity to treat cancer cell types. Centrose’s EDC5 targets the cell surface of cancer cells that is responsible for recirculation, homing, multi-drug resistance, lymphocyte activation, and metastasis of many solid tumors. Its extracellular drug conjugate system includeo; a drug, a binding component that targets diseased cells. The company serves its clients across the US. Centrose is headquartered in Madison, Wisconsin, the US.

Centrose LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centrose LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centrose LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centrose LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Centrose Raises USD0.2 Million in Venture Financing 10
Centrose Raises USD1 Million in Venture Financing 11
Centrose To Raise US$0.5 Million In Venture Financing 12
Centrose LLC – Key Competitors 13
Centrose LLC – Key Employees 14
Centrose LLC – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Centrose LLC, Pharmaceuticals & Healthcare, Key Facts 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centrose LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centrose LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Centrose LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centrose Raises USD0.2 Million in Venture Financing 10
Centrose Raises USD1 Million in Venture Financing 11
Centrose To Raise US$0.5 Million In Venture Financing 12
Centrose LLC, Key Competitors 13
Centrose LLC, Key Employees 14

List of Figures
Centrose LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centrose LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centrose LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centrose LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Nizhnekamskneftekhim (NKNC):企業の財務・戦略的SWOT分析
    Nizhnekamskneftekhim (NKNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Oxford Biodynamics Plc-医療機器分野:企業M&A・提携分析
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, …
  • Nexeon MedSystems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery …
  • Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Senju Pharmaceutical Co Ltd (Senju) researches, develops, manufactures and markets pharmaceutical products for eye, ear, nose, throat, and skin. The company offers a wide range of ophthalmological products. Its product portfolio includes prescription products, OTC medicines and veterinary dr …
  • Fraser and Neave, Limited:企業の戦略・SWOT・財務情報
    Fraser and Neave, Limited - Strategy, SWOT and Corporate Finance Report Summary Fraser and Neave, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Upsher-Smith Laboratories Inc:企業のM&A・事業提携・投資動向
    Upsher-Smith Laboratories Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Upsher-Smith Laboratories Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Hanmi Pharmaceuticals Co Ltd (128940):製薬・医療:M&Aディール及び事業提携情報
    Summary Hanmi Pharmaceuticals Co Ltd (Hanmi Pharma), a subsidiary of Hanmi Science Co Ltd is a developer of prescription drugs and over the counter drugs. The company’s prescription drugs include osteoporosis, antibiotics, antidiarrheal, liver supplements and antiemetics. It provides over the counte …
  • Golden Meditech Holdings Ltd (801):企業の財務・戦略的SWOT分析
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • Smiths Group plc:企業の戦略・SWOT・財務情報
    Smiths Group plc - Strategy, SWOT and Corporate Finance Report Summary Smiths Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tesla, Inc (TSLA):電力:M&Aディール及び事業提携情報
    Summary Tesla, Inc. (Tesla), formerly Tesla Motors, Inc., is an automotive and vertically integrated sustainable energy company. It designs, develops, manufactures and sells electric vehicles and energy storage products. The company also installs and maintains electric vehicles and energy storage sy …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Shoppers Drug Mart Corporation:企業の戦略・SWOT・財務情報
    Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report Summary Shoppers Drug Mart Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cambrex Corp (CBM):企業の財務・戦略的SWOT分析
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • Vinnolit GmbH & Co KG:企業の戦略的SWOT分析
    Vinnolit GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Emera (Caribbean) Inc.:発電所・企業SWOT分析
    Emera (Caribbean) Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Great Eastern Energy Corp Ltd (GEEC):企業の財務・戦略的SWOT分析
    Summary Great Eastern Energy Corp Ltd (GEECL), a subsidiary of YKM Holdings Pvt Ltd, is an oil and gas exploration and production company. The company carries out extraction and sale of coal bed methane coalbed methane gas. It operates upstream, midstream and downstream projects in Raniganj south bl …
  • Chugai Pharmaceutical Co Ltd (4519):製薬・医療:M&Aディール及び事業提携情報
    Summary Chugai Pharmaceutical Co Ltd (Chugai) is a subsidiary of Hoffmann-La Roche Ltd, which focuses on the research, development, manufacture, commercialization, import and export of the biopharmaceuticals and therapeutic antibodies. The company offers products for the treatment of cancer; bone an …
  • Lensar Inc:医療機器:M&Aディール及び事業提携情報
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆